Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over ...

Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ratings for the ...

Sarat Sethi says Zoetis stock is a better pick than Elanco for 2025. He explained his view in a recent interview with CNBC.

Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...

Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

Shares in pharmaceuticals firm Eli Lilly (LLY) rose today after it said it was suing companies ripping off its weight-loss ...

The Vanguard Dividend Appreciation ETF (VIG) has crashed this year and has formed a death cross pattern, pointing to more ...

Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

Real-time index price for TSX Composite High Dividend Index (TXEI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...